COMP <GO>
LCID vs PG // FORWARD P/E MULTIPLE
Lucid Group Inc. (NASDAQ) VS. Procter & Gamble Company (The) (NYSE) • 15-METRIC TALLY: LCID 2
— PG 12
▲ FORWARD P/E MULTIPLE LEADER: PG
LAST: $3.02 (-5.62%) • MKT CAP: $1.26B
forward-pe
23.0x
LAST: $161.57 (+0.61%) • MKT CAP: $372.21B
forward-pe
21.7x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (LCID VS. PG)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | LCID | PG | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | -30.00% | 51.20% | -81.20 | PG | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | 25.40% | -60.40 | PG | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 16.2x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -18.00% | 3.77% | -21.77 | PG | /fcf-yield <GO> |
| Operating Margin | -60.00% | 24.30% | -84.30 | PG | /operating-margins <GO> |
| Net Profit Margin | -60.00% | 19.00% | -79.00 | PG | /net-margins <GO> |
| Revenue Growth (YoY) | 67.60% | 0.30% | +67.30 | LCID | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.65% | -2.65 | PG | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.45 | 5.59 | -5.14 | PG | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 7/9 | -4.00 | PG | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.30% | 6.50% | +0.80 | PG | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 33.3 | 62.7 | -29.42 | PG | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.12 | 0.87 | +0.25 | LCID | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | 23.0x | 21.7x | +1.30 | PG | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.26B | $372.21B | -$370.95B | PG | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | LCID REV | PG REV | LCID GROSS % | PG GROSS % | LCID FCF | PG FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.35B | $84.28B | -92.8% | 51.2% | -$3.80B | $14.04B |
| FY 2024 | $807.8M | $84.04B | -114.3% | 51.4% | -$2.90B | $16.52B |
| FY 2023 | $595.3M | $82.01B | 44.0% | 44.0% | -$2.52B | $13.16B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
LCID // BETA 1.12
PG // BETA 0.87